Biotech ETFs Can be Solid Again in 2018

The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech exchange traded fund by assets, is up 20% year-to-date, a solid showing following a rare slump for the biotech sector in 2016. Some market observers believe biotechnology stocks and ETFs can repeat their bullish 2017...